Discovery to Clinical Supply
Integrated drug development support from early research through clinical trial readiness
Connecting Development and Clinical Execution
Advancing a therapeutic candidate from discovery into clinical development requires coordination across chemistry, formulation, analytical testing, manufacturing, and supply chain operations. MRIGlobal brings these capabilities together to help reduce development risk, shorten timelines, and provide a smoother path toward clinical evaluation.
Accelerating Drug Development
API Development & Manufacturing
Develop and optimize synthetic processes that support reliable production of active pharmaceutical ingredients.
Formulation Development
Design and optimize formulations that improve product performance, manufacturability, and stability.
Analytical Development & Testing
Generate the analytical data needed to support product development, quality assessment, and regulatory decision-making.
Process Scale-Up
Advance laboratory scale processes toward clinical manufacturing through scalable development activities.
Clinical Manufacturing Support
Produce and test materials needed for clinical studies under appropriate quality systems.
Clinical Supply Management
Support storage, packaging, labeling, and distribution activities needed to deliver investigational products to clinical trial sites.
Latest from the blog
-
Safeguarding a Clinical Trial Amid Regulatory and Logistical Constraints
Expertise enabled client to proceed without delay
Clinical Trial Materials Management Foreign-Trade Zone Warehouse & Distribution -
Trouble with Tariffs?
On Thursday, Sept. 25, President Trump announced 100% tariffs on some imported brand-name drugs starting October 1, unless manufacturers build U.S. plants to boost domestic production. As this new tariff policy is enacted, it may have an adverse impact on pharmaceutical companies by increasing the cost of importing raw materials, drug substances and drug products, […]
Clinical Trial Materials Management Foreign-Trade Zone Warehouse & Distribution -
Generic Drug Development
Generic pharmaceuticals make up nine out of every 10 prescriptions in the United States. And in 2025, drugs for COPD, hypertension, high cholesterol, cancer, and many other disease conditions have expiring patents, so can be produced as generics. These drugs are as effective and work the same as the name brands, but typically cost consumers […]
Clinical Trial Materials Management Drug Product Synthesis & API Manufacturing
